Key points are not available for this paper at this time.
The preparation of MgAl Layer Double Hydroxide (LDH) was performed using the coprecipitation method. Pristine MgAl LDH was calcined at 500°C to produce the MgAl Layer Double Oxide (LDO). The two materials were modified via restacking-delaminating the bioactive compounds from the flower extract of Clitoria ternatea (CT) to produce MgAl LDH-CT and MgAl LDO-CT. Modifications are performed to enhance the stability of the catalyst structure, allowing its higher photocatalytic activities and regeneration use. The prepared catalysts were characterized using XRD, FT-IR, UV-DRS, BET, and SEM-EDX. The XRD diffraction pattern showed that the three catalysts have typical diffraction patterns commonly observed in LDH-based materials. FT-IR spectra confirmed that MgAl LDH-CT and MgAl LDO-CT showed combined spectra of its precursor materials. MgAl LDO-CT has the lowest bandgap energy with the highest degradation kinetics. BET and SEM-EDX characterization shows uniform surface and pore size on MgAl LDO-CT. The prepared catalysts were used in the ciprofloxacin photodegradation under UV light. The optimal catalyst dose was 5 mg, while the optimal pH was 5. MgAl LDO-CT, MgAl LDH-CT, and MgAl LDH showed ciprofloxacin degradation capacity up to 73.300%, 65.739%, and 71.320%, respectively, within 120 minutes. Repeated use of the catalyst up to the third cycle resulted in %R reaching 80.871%, 74.003%, and 52.025%, respectively, by MgAl LDH-CT, MgAl LDO-CT, and MgAl LDH. Compared to pristine MgAl LDH, the CT intercalated catalysts exhibited more excellent stability.
Rohmatullaili et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: